Research Grants
L’Institut Servier Research Grants are awarded for one year of research, enabling:
- French researchers, future PhDs or postdocs in medicine or pharmacy wishing to acquire additional training and/or supplement their research project abroad.
- Or foreign researchers, future PhDs or postdocs wishing to supplement their training in France, with priority given to the following therapeutic areas: oncology, immuno-inflammatory diseases, neurodegenerative diseases, and paediatric diseases.
Eligibility criteria:
- Reason for the mobility and why it is necessary
- Candidate’s scientific studies and publications
- Project utility, relevance and scientific quality
- Candidate’s personal implication in the project
- Added value for the research team
- Candidate’s plans for further study after project completion
Grant Winners of the October 2023 session
- Sylvain BODARD
Research Project: “Super-resolution ultrasound imaging of normal and pathological renal parenchyma aided by deep-learning“.
Host laboratory: Pr Leonardo V. RIELLA, Massachusetts General Hospital, Boston, USA
- Benoît BRILLAND
Research Project: “Transcriptomic analysis in severe autoimmune diseases“.
Host laboratory: Dr David LANGLAIS, Mc GILL University, Montreal, Quebec, Canada
- Elsa FEREDJ
Research Project: “Identification and characterization of novel genetic etiologies underlying tuberculosis disease“.
Host laboratory: Pr Jean-Laurent CASANOVA, Rockefeller University Hospital, New-York, USA
- Jonathan GARNIER
Research Project: “Pancreatectomy with complex vascular reconstruction, which patient and what is the alternative?”
Host laboratory: Pr Christopher L. WOLFGANG, NYU Langone Health, N-Y, USA/ Pr Marc BESSELINK, Amsterdam UMC, Netherlands
- Nicolas GENDRON
Research Project: ““Evaluation of combination of a PAD4 inhibitor and ADAMTS13 to target NETosis in cancer associated thrombosis”.
Host laboratory: Pr Denisa WAGNER, Boston Children’s Hospital, Boston, USA
- Zine-Eddine KHENE
Research Project: “Development and validation of a radiopathomics model to predict recurrence after surgical resection of non- metastatic clear-cell renal cell carcinoma“.
Host laboratory: Pr Yair LOTAN, UT Southwestern Medical Center, Dallas, USA
- Amira MAROUF
Research Project: “Identification and targeting of treatment induced resistance mechanisms to novel immunomodulating agents in relapsed or refractory Mantle Cell Lymphoma“.
Host laboratory: Pr Santosha VARDHANA, Memorial Sloan Kettering Cancer Center, N-Y, USA
- Grégoire MARTIN DE FREMONT
Research Project: “Pathogenesis of congenital heart block in anti-SSA auto-antibodies exposed newborns“.
Host laboratory: Pr Marie WAHREN-HERLENIUS, Karolinska Institutet, Stockholm, Sweden
- Violaine RANDRIAN
Research Project: “Inducing anti-tumoral immunity through hypersensitivity to Interferon ƴ”.
Host laboratory: Pr Luis DIAZ, Memorial Sloan Kettering Cancer Center, New-York, USA
- Manon DE VRIES-BRILLAND
Research Project: “Role of immune checkpoint inhibitors and comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma: a prospective validation cohort”.
Host laboratory: Pr Denis SOULIERES and Dr Zineb HAMILOU, University of Montreal Hospital, Quebec, Canada
- Nader YATIM
Research Project: “Tissue-specific contribution of clonal hematopoiesis to macrophages in homeostatic and pathogenic inflammation”.
Host laboratory: Pr Miriam MERAD, Mount Sinai Hospital, New-York, USA